Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide plus metformin vs metformin alone in children and adolescents with type 2 diabetes
2011-002605-29Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Apr 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Liraglutide + metformin with Metformin + placebo (2 arms). Primary endpoint: Change in HbA1c. Started Apr 2012; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2011-002605-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002605-29.